Deep learning diagnosis plus kinematic severity assessments of neurodivergent disorders.

Publication date: Jul 08, 2025

Early diagnostic assessments of neurodivergent disorders (NDD), remains a major clinical challenge. We address this problem by pursuing the hypothesis that there is important cognitive information about NDD conditions contained in the way individuals move, when viewed at millisecond time scales. We approach the NDD assessment problem in two complementary ways. First, we applied supervised deep learning (DL) techniques to identify participants with autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), comorbid ASD + ADHD, and neurotypical (NT) development. We measured linear and angular kinematic variables, using high-definition kinematic Bluetooth sensors, while participants performed the reaching protocol to targets appearing on a touch screen monitor. The DL technique was carried out only on the raw kinematic data. The area under the receiver operator characteristics curve suggests that we can predict, with high accuracy, NDD participant’s conditions. Second, we filtered the high frequency electronic sensor noise in the recorded kinematic data leaving the participants’ physiological characteristic random fluctuations. We quantified these fluctuations by their biometric Fano Factor and Shannon Entropy from a histogram distribution built from the magnitude difference between consecutive extrema unique to each participant, suggesting a relationship to the severity of their condition. The DL may be used as complementary tools for early evaluation of new participants by providers and the new biometrics allow for quantitative subtyping of NDDs according to severity.

Open Access PDF

Concepts Keywords
Autism Adolescent
Biometrics Adult
Bluetooth Autism Spectrum Disorder
Neurodivergent Biomechanical Phenomena
Relationship Child
Deep Learning
Female
Humans
Male
Young Adult

Semantics

Type Source Name
disease MESH autism spectrum disorder
disease MESH ADHD
drug DRUGBANK Coenzyme M
drug DRUGBANK Methylergometrine
drug DRUGBANK Saquinavir
disease MESH confusion
drug DRUGBANK Hyaluronic acid
disease MESH comorbidity
disease MESH Developmental Disabilities
pathway REACTOME Pervasive developmental disorders
disease MESH autism
disease MESH psychiatric disorders
disease MESH syndrome
disease MESH postures
disease MESH abnormalities
drug DRUGBANK Serine
pathway REACTOME Reproduction

Original Article

(Visited 3 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *